Mitsubishi UFJ Asset Management (UK)’s Mondelez International MDLZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,000
Closed -$405K 112
2025
Q2
$405K Sell
6,000
-2,000
-25% -$133K 0.21% 91
2025
Q1
$543K Buy
8,000
+6,000
+300% +$370K 0.3% 79
2024
Q4
$119K Sell
2,000
-5,000
-71% -$331K 0.05% 110
2024
Q3
$516K Buy
+7,000
New +$492K 0.27% 95
2019
Q4
Sell
-19,200
Closed -$1.07M 87
2019
Q3
$1.07M Sell
19,200
-20,000
-51% -$1.09M 0.5% 53
2019
Q2
$2.11M Sell
39,200
-5,000
-11% -$260K 0.92% 38
2019
Q1
$2.21M Hold
44,200
1.08% 31
2018
Q4
$1.77M Buy
44,200
+22,100
+100% +$942K 0.89% 35
2018
Q3
$949K Hold
22,100
0.46% 75
2018
Q2
$906K Sell
22,100
-15,000
-40% -$603K 0.51% 67
2018
Q1
$1.55M Sell
37,100
-34,000
-48% -$1.48M 1.04% 42
2017
Q4
$3.04M Hold
71,100
2.19% 18
2017
Q3
$2.91M Hold
71,100
2.28% 16
2017
Q2
$3.07M Buy
+71,100
New +$3.21M 2.72% 11

Other funds holding MDLZ

Mitsubishi UFJ Asset Management (UK)'s MDLZ Position: Q3 2025 in Review

Mitsubishi UFJ Asset Management (UK) sold out of Mondelez International (MDLZ) in Q3 2025, closing a stake of 6,000 shares — an estimated $405K sold.

Mitsubishi UFJ Asset Management (UK) first reported a position in MDLZ in Q2 2017 and held it in 14 quarters. The position peaked at $3.07M in Q2 2017. 1,933 funds tracked by Wall St. Rank hold MDLZ as of Q3 2025.

  • Mitsubishi UFJ Asset Management (UK) reported no remaining Mondelez International position as of Q3 2025 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management (UK) sold 6,000 Mondelez International shares in Q3 2025, an estimated $405K.
  • Mitsubishi UFJ Asset Management (UK) first reported a position in Mondelez International in Q2 2017 and held it in 14 quarters.
  • Mitsubishi UFJ Asset Management (UK)'s Mondelez International position peaked at $3.07M in Q2 2017.
  • 1,933 funds tracked by Wall St. Rank held Mondelez International as of Q3 2025.

Based on Mitsubishi UFJ Asset Management (UK)'s 13F filing for Q3 2025, filed 10 Nov 2025.